Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v12-EN | Version v8-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2020-03-21 | 2020-02-19 |
| Drug Identification Number | 00828750 | 00828750 |
| Brand name | HEPARIN SOD AND 0.9% SOD CHLORIDE INJ | HEPARIN SOD AND 0.9% SOD CHLORIDE INJ |
| Common or Proper name | Heparin in Sodium Chloride Injection | Heparin in Sodium Chloride Injection |
| Company Name | BAXTER CORPORATION | BAXTER CORPORATION |
| Ingredients | SODIUM CHLORIDE HEPARIN | SODIUM CHLORIDE HEPARIN |
| Strength(s) | 9MG 2UNIT | 9MG 2UNIT |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 500 mL | 500 mL |
| ATC code | B01AB | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | 2020-01-28 | 2020-01-28 |
| Actual start date | 2020-01-28 | 2020-01-28 |
| Estimated end date | 2020-03-20 | 2020-03-30 |
| Actual end date | 2020-03-20 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |